CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 73 filers reported holding CHEMOCENTRYX INC in Q4 2015. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,590,000 | -27.1% | 1,414,515 | 0.0% | 1.01% | -29.9% |
| Q2 2019 | $13,155,000 | -35.3% | 1,414,515 | -3.4% | 1.44% | -36.9% |
| Q1 2019 | $20,342,000 | -72.1% | 1,464,515 | -78.1% | 2.28% | -76.1% |
| Q4 2018 | $72,961,000 | -14.8% | 6,687,523 | -1.3% | 9.54% | +26.7% |
| Q3 2018 | $85,620,000 | -7.6% | 6,773,760 | -3.7% | 7.52% | -16.8% |
| Q2 2018 | $92,642,000 | -5.4% | 7,034,346 | -2.3% | 9.04% | -8.9% |
| Q1 2018 | $97,938,000 | +116.9% | 7,201,316 | -5.1% | 9.93% | +82.4% |
| Q4 2017 | $45,145,000 | -19.8% | 7,587,416 | 0.0% | 5.44% | -24.0% |
| Q3 2017 | $56,299,000 | -27.1% | 7,587,416 | -8.0% | 7.16% | -40.3% |
| Q2 2017 | $77,205,000 | +32.7% | 8,248,416 | +3.2% | 11.99% | +21.2% |
| Q1 2017 | $58,171,000 | +0.8% | 7,990,572 | +2.5% | 9.89% | -14.7% |
| Q4 2016 | $57,709,000 | +18.5% | 7,798,572 | -3.3% | 11.60% | +26.3% |
| Q3 2016 | $48,707,000 | +32.6% | 8,064,019 | -1.4% | 9.18% | +17.3% |
| Q2 2016 | $36,737,000 | +80.3% | 8,182,052 | 0.0% | 7.83% | +55.3% |
| Q1 2016 | $20,373,000 | -62.3% | 8,182,052 | +22.5% | 5.04% | -45.3% |
| Q4 2015 | $54,090,000 | +18.0% | 6,677,722 | -11.8% | 9.22% | -0.4% |
| Q3 2015 | $45,820,000 | -23.4% | 7,573,493 | +4.2% | 9.26% | -12.3% |
| Q2 2015 | $59,832,000 | -4.6% | 7,270,013 | -12.4% | 10.56% | -19.4% |
| Q1 2015 | $62,688,000 | +6.8% | 8,303,084 | -3.4% | 13.11% | +14.8% |
| Q4 2014 | $58,716,000 | +51.8% | 8,596,772 | 0.0% | 11.42% | +42.2% |
| Q3 2014 | $38,685,000 | -19.2% | 8,596,772 | +5.1% | 8.03% | +6.1% |
| Q2 2014 | $47,864,000 | -7.4% | 8,181,816 | +4.9% | 7.57% | -5.5% |
| Q1 2014 | $51,691,000 | +14.5% | 7,796,516 | 0.0% | 8.01% | +1.5% |
| Q4 2013 | $45,142,000 | +51.0% | 7,796,516 | +45.0% | 7.90% | +53.5% |
| Q3 2013 | $29,900,000 | -57.9% | 5,377,616 | +7.0% | 5.14% | -62.7% |
| Q2 2013 | $71,078,000 | – | 5,026,766 | – | 13.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |